<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Fosun Pharma USA Inc., et al.; Withdrawal of Approval of 23 Abbreviated New Drug Applications; Correction</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Fosun Pharma USA Inc., et al.; Withdrawal of Approval of 23 Abbreviated New Drug Applications; Correction</h1>
    <p class="timestamp">Published: 2024-12-30 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on July 29, 2024. The document announced the withdrawal of approval of 23 abbreviated new drug applications (ANDAs) from multiple applicants, withdrawn as of August 28, 2024. The document indicated that FDA was withdrawing approval of the ANDAs 073462 for tolmetin sodium capsules, equivalent to (EQ) 400 milligrams (mg) base; 073588 for tolmetin sodium tablets, EQ 200 mg base; 074002 for tolmetin s...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2024-31307</p>
    <p><strong>Publication Date:</strong> 2024-12-30</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2024/12/30/2024-31307/fosun-pharma-usa-inc-et-al-withdrawal-of-approval-of-23-abbreviated-new-drug-applications-correction">https://www.federalregister.gov/documents/2024/12/30/2024-31307/fosun-pharma-usa-inc-et-al-withdrawal-of-approval-of-23-abbreviated-new-drug-applications-correction</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2024-31307</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
